Keywords: blow, lilly, reopro, shows, benefit, medical, therapy

Blow to Lilly as ReoPro shows no benefit as medical therapy in unstable

Article | 29 August 2000

Print This

Eli Lilly and partner Johnson & Johnson have been dealt a blow followingthe release of data at the European Society of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in